Narrow search
Showing 1 - 10 of 2,308
Cover Image
Estimating and explaining the efficiency of township hospitals in Shandong province in the context of the drug policy reform
Petitfour, Laurene; Huangfu, Xiezhe; Audibert, Martine; … - 2015
Persistent link: https://www.econbiz.de/10011300733
Cover Image
India's proposed universal health coverage scheme : implications for the global pharma industry
Singh, Sunil; Outteridge, Gavin - In: Journal of medical marketing : device, diagnostic and … 13 (2013) 3, pp. 181-193
Persistent link: https://www.econbiz.de/10009791593
Cover Image
Pharmaceutical benefit scheme and cost containment in Taiwan's National Health Insurance
Huang, Weng-Foung; Chiang, Hung-Chi - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 2, pp. 133-149
Persistent link: https://www.econbiz.de/10002185666
Cover Image
Public health insurance and pharmaceutical innovation : evidence from China
Zhang, Xuan; Nie, Huihua - In: Journal of development economics 148 (2021), pp. 1-27
Persistent link: https://www.econbiz.de/10012658986
Cover Image
Medical providers as double agents in a universal health care system : evidence from generic pharmaceutical adoption in Taiwan
Tang, Meng-Chi; Wu, Yi-Nong - In: Empirical economics : a journal of the Institute for … 59 (2020) 1, pp. 169-203
Persistent link: https://www.econbiz.de/10012253187
Cover Image
Reframing the pharmaceutical sector contribution to access to medicines and universal health coverage : a business ethics perspective
Fürst, Michael - In: The road to universal health coverage : innovation, …, (pp. 142-173). 2018
Persistent link: https://www.econbiz.de/10012029416
Cover Image
Physicians as Double Agents in a Universal Health Care System : Evidence from Generic Pharmaceutical Adoption in Taiwan
Tang, Meng-Chi - 2016
Physicians’ generic pharmaceutical adoption involves not only patients’ and insurance payers’ cost, but also their own interests. This study examines this double agency problem for physicians by using Taiwanese data because two of its institutional features: First, patients and physicians...
Persistent link: https://www.econbiz.de/10014129240
Cover Image
The January effect: medication reinitiation among Medicare part D beneficiaries
Kaplan, Cameron; Zhang, Yuting - In: Health economics 23 (2014) 11, pp. 1287-1300
Persistent link: https://www.econbiz.de/10011308176
Cover Image
Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market : evidence from Taiwan
Liu, Ya Ming; Hsieh, Chee-Ruey - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 241-275
Persistent link: https://www.econbiz.de/10010345585
Cover Image
Should pharmaceutical costs be curbed?
Brekke, Kurt R.; Dalen, Dag Morten; Strøm, Steinar - In: Nordic economic policy review (2012) 2, pp. 247-273
Persistent link: https://www.econbiz.de/10010379568